I have been interested in the care of cancer patients since I was a junior at the University of Notre Dame. My training at the Indiana University School of Medicine gave me strong clinical skills, but my Oncology training at the University of Michigan helped me realize the need for better treatment for our patients. Lung cancer research is behind many of the other cancers and better therapy is desperately needed for a disease that afflicts over 160,000 Americans annually. I was offered a faculty position at every major medical center in the city, but chose Weill Cornell because of the sincere commitment to excellent patient care while fostering cutting-edge research to help take better care of future patients.
Dr. Bryan J. Schneider is an Assistant Professor of Medicine in the department of Internal Medicine, Division of Hematology/Oncology at New York Presbyterian-Weill Cornell Medical Center.
Dr. Schneider completed his undergraduate studies at the University of Notre Dame in 1994. He pursued his medical education at Indiana University School of Medicine and graduated from the program in 1998. He completed his Internal Medicine Residency training at Indiana University Medical Center, Indianapolis, in 2001, and served as Chief Resident the following year. After completion of his Hematology and Medical Oncology Fellowship at the University of Michigan in Ann Arbor, he assumed the position of Assistant Professor in Medicine at the University of Michigan Comprehensive Cancer Center until 2008.
Dr. Schneider teaches medical students, residents and Hematology/Oncology fellows on all levels. He is a member of numerous medical societies, including the American Society of Clinical Oncology and the International Association for the Study of Lung Cancer. His research focuses on the development of more effective and less toxic therapy for lung and esophageal cancer.
1998 Indiana University School of Medicine
Residency: 2002 Indiana University Hospital
Fellowship: 2005 University of Michigan Hospital